Cargando…
TNFα Cooperates with IFN-γ to Repress Bcl-xL Expression to Sensitize Metastatic Colon Carcinoma Cells to TRAIL-mediated Apoptosis
BACKGROUND: TNF-related apoptosis-inducing ligand (TRAIL) is an immune effector molecule that functions as a selective anti-tumor agent. However, tumor cells, especially metastatic tumor cells often exhibit a TRAIL-resistant phenotype, which is currently a major impediment in TRAIL therapy. The aim...
Autores principales: | Liu, Feiyan, Hu, Xiaolin, Zimmerman, Mary, Waller, Jennifer L., Wu, Ping, Hayes-Jordan, Andrea, Lev, Dina, Liu, Kebin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022032/ https://www.ncbi.nlm.nih.gov/pubmed/21264227 http://dx.doi.org/10.1371/journal.pone.0016241 |
Ejemplares similares
-
Bcl-XL and Bcl-2 repress a common pathway of cell death
Publicado: (1995) -
IFN-γ Upregulates Survivin and Ifi202 Expression to Induce Survival and Proliferation of Tumor-Specific T Cells
por: Zimmerman, Mary, et al.
Publicado: (2010) -
Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL
por: Hari, Yoko, et al.
Publicado: (2015) -
Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell Lymphoma
por: Luanpitpong, Sudjit, et al.
Publicado: (2022) -
Bcl-xL in neuroprotection and plasticity
por: Jonas, Elizabeth A., et al.
Publicado: (2014)